Magpale, Rodelyn O.
HRN: 22-81-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2023
CEFUROXIME 750MG (VIAL)
04/01/2023
04/08/2023
IV
750 Mg
Q8hours
UTI
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Non-compliant To Guidelines